Dongwha Pharm.Co.,Ltd (KRX:000020)

Market Cap	169.08B +0.7%
Revenue (ttm)	493.33B +15.1%
Net Income	7.59B -1.0%
EPS	273.72 -1.2%
Shares Out	27.72M
PE Ratio	22.29
Forward PE	n/a
Dividend	180.00 (2.95%)
Ex-Dividend Date	Mar 24, 2026

Volume	69,507
Average Volume	131,871
Open	6,060.00
Previous Close	6,100.00
Day's Range	5,960.00 - 6,170.00
52-Week Range	5,560.00 - 7,140.00
Beta	0.34
RSI	47.75
Earnings Date	Feb 20, 2026

About Dongwha Pharm.Co.,Ltd

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health su...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 827
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 000020

Financial Performance

In 2024, Dongwha Pharm.Co.,Ltd's revenue was 464.87 billion, an increase of 28.74% compared to the previous year's 361.11 billion. Earnings were 5.56 billion, a decrease of -79.72%.